Member Info for Dustbin101

SkinBioTherapeutics is under a strict confidentiality agreement that prevents it from divulging information on sales or providing market forecasts.

Thus : SBTX shareholders will know the numbers twice a year in the interim, and full year results.

Plus just been told today all is going to plan.

Plus Croda have very high expectations

Plus Croda have sales teams in 114 countries

Plus it’s a first proven sleep cosmetic

Plus it’s produced and sold by the worlds number 2 in cosmetic actives

Plus SBTX picks up 10% or more from sales

Plus it’s going to be in all the shops

Plus it’s does what requires 5 different ingredients to do today

Correct , the loons never understand that it’s profits that drive share prices

Zenakine has all that’s required, to see SBTX shares rocket.

Ashman has even told you sales can only go north ( up)

He knows the numbers, he just can’t share them.

Zenakine the first cosmetic sleep and anti ageing solution , plus , plus, plus,

Produced and sold by the worlds no 2 in cosmetic Actives

**That's the dream. Only issue is, a lot of livings are made with dreams - we have no such luxury**

Yer right like my 63 bagger and 232 bagger from stocks that were not a patch on Zenakine .

lol

I have no need to , thanks.

Blockbusters in the early days are unknown, then sales go through the roof.

Think Apple, YouTube, and the fat busting drugs

Its one and only purpose is to protect CRODA’S profits.

Thats what you do when you have a blockbuster product or service.

Both parties have agreed to an extension

Both parties are talking about other uses of Zenakine outside cosmetics.

Both parties are in bid talks with each other

Croda are in take over talks with others, ( not SBTX ) re being taken over, themselves.

The NDA may end after 3 months as Ashman said two weeks ago, ( in 8 or so days time, he thought he would have been able to pull it forward till June 30th. ) This may have failed .

He did not, he said he can’t give numbers, but the broker can .

Toyin, stop the bleating, you get to see the numbers twice a year

You get a broker note that will have forecasts

You have a blockbuster, Croda have no intention of screwing it up , to please you desire for instant numbers .

Stop the blame game and look for the logical reasons for an NDA.

Knowing numbers now has ZERO effect on profit or Zenakine sales outcomes

No end of the world’s population has poor sleep

———————————

**It is the first ingredient with clinical instrumental measures on sleep quality and duration benefits.**

—————————-

This is so huge , it’s off the scale, when it comes to selling a cream, not a drug / pill.

Consumer's will go nuts for it .!!!

So will the cosmetic companies !!!

1/ It informs SBTX all is on track as expected. ( potential blockbuster ).

2/ It is designed to increase and protect CRODA’S profits from Zenakine, this does exactly the same for SBTX shareholders as we get a 10% plus cut of Zenakine sales.

3/ The NDA also gives those when have bought Zenakine the chance to have meaningful marketing for new product's

4/ The SBTX house broker CAN make forecasts and judgements of sales of Zenakine.

5/ Zenakine sales WILL show up in the SBTX accounts, twice a year

The beauty industry is poised for monumental transformation through the summer of 2025 as it navigates the evolving demands of consumers. According to data from Statistaa, the industry is projected to generate $104.7 billion in the U.S. by the end of 2025, the sector is continuing to lean heavily into sustainability, personalization, biotech advancements, social commerce, and diversity.

Sustainability has become a cornerstone, with over 65% of consumers seeking environmentally friendly brands according to data Google Cloudb This has led to a surge in demand for "clean" and "natural" products.

Https://gcimagazine.texterity.com/gcimagazine/library/item/june_2025/4277706/?oly_enc_id=6222I0681890F3A

Mr humble has a 99% chance of failure, as he always expresses his own track record, on AIM. .!!

Yes, plus kids these days will only buy natural products

The stamp of approval from America will also drive sales.

The trick being , to give Superdrug a high margin , to promote it , above all others.

Repeat sales is the name of the game.

Poor Mr Humble

Croda revenue numbers do not change , no matter what date they arrive in the public domain.

Croda will never break them down within their 4BN of revenues.

Zenakine revenues are going one way and that is up

SkinBioTherapeutics PLC IMC Shareholder Presentation next week.

Placing shareholders RNS ( new holdings )

Broker report, first research note ( due next week, after SBTX year end on Monday )

This might already be in the hands of those who work in the city .

Trading update late July / early August

Trading update shareholder presentation. ( August)

Will he be knocked off his position by the close of play .?

Left on the offer

Yep , like NTA at 2p to £1.32p

Bless